Ginkgo Bioworks Holdings, Inc.
DNA· NYSE
Released May 6, 2025, after the close
10-Q filed May 6, 2025, 36 days after period end · 0001628280-25-022761
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Revenue | $38.23M | $37.94M | $80.70M | $168.41M |
| Net Income | -$90.96M | -$165.91M | -$204.97M | -$590.51M |
| EPS Diluted |
Ginkgo Bioworks Holdings, Inc. · CIK 1830214 · Engraved from SEC EDGAR
| -$1.68 |
| -$3.32 |
| -$0.11 |
| -$0.37 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.